Cargando…

Influence of nutrients, bioactive compounds and plant extracts in liver diseases /

Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases provides evidence-based knowledge of the mechanism of action of natural compounds, as well as the relation of structure and function of phytochemicals in hepatitis B and C, fatty liver disease, nonalcoholic fatty liver...

Descripción completa

Detalles Bibliográficos
Clasificación:	Libro Electrónico
Otros Autores:	Alavian, Seyed Moayed
Formato:	Electrónico eBook
Idioma:	Inglés
Publicado:	London : Academic Press, 2021.
Temas:	Liver > Diseases > Nutritional aspects. Phytochemicals. Compos�es phytochimiques. Liver > Diseases > Nutritional aspects Phytochemicals
Acceso en línea:	Texto completo

Tabla de Contenidos:

Intro
Influence of Nutrients, Bioactive Compounds and Plant Extracts in Liver Diseases
Copyright
Dedication
Contents
Contributors
Preface
Chapter 1 Introduction
References
Part 1 Hepatoprotective activity of natural compounds and plant extracts in liver diseases
Chapter 2 Hepatitis B
2.1 Introduction
2.2 Rheum palmatum L.
2.3 Ganoderma lucidum (Curtis) P. Karst.
2.4 Oenanthe javanica (Blume) DC.
2.5 Curcuma longa L.
2.6 Phyllanthus amarus Schum. and Thonn.
2.7 Phyllanthus niruri L.
2.8 Swertia patens Burkill
2.9 Boehmeria nivea (L.) Gaudich.
2.10 Role of natural compounds in ameliorating hepatitis B
2.10.1 Terpenoids
2.10.2 Lignans
2.10.3 Phenolic acids
2.10.4 Polyphenols
2.10.5 Alkaloids
2.11 Conclusion
Acknowledgments
Conflict of interest
References
Further reading
Chapter 3 Hepatitis C
3.1 Introduction
3.2 Etiology
3.3 Signs and symptoms
3.4 Genotypes and serotypes of HCV
3.5 Diagnosis (serology, biopsy, and screening)
3.6 Serology
3.7 Screening tests
3.7.1 Enzyme immunosorbent assay (EIA)
3.7.2 The rapid test (point of care test)
3.7.2.1 Confirmatory tests
3.8 Biopsy
3.9 Screening
3.10 Prevention
3.11 Treatment
3.12 Hepatoprotective activity of natural compounds and plant extracts in Hepatitis C
3.12.1 Silymarin
3.12.2 Naringenin
3.12.3 Quercetin
3.12.4 ( )-Epigallocatechin-3-gallate (EGCG)
3.12.5 Luteolin and apigenin
3.12.6 Honokiol
3.12.7 3-Hydroxy caruilignan C (3-HCL-C)
3.12.8 Ladanein
3.12.9 Plumbagin
3.12.10 Corilagin
3.13 Conclusion
Conflict of interest
References
Chapter 4 Alcoholic liver disease
4.1 Introduction
4.2 The cause and consequences of alcohol toxicity.
4.2.1 Alcohol metabolism and oxidative stress
4.2.2 Genetic alterations in developing of alcoholic liver diseases
4.2.3 The role of cytokines, chemokines, and adipocytokines in alcoholic liver disease
4.2.4 Sex differences in alcohol sensitivity
4.3 Alcohol as a depressant
4.4 Complex treatment of alcohol disease
4.4.1 Treatment of alcoholic liver diseases with vitamin supplements, nutrition, and medicaments with natural ingredi ...
4.4.2 Some traditional herbal medicines in complex treatment of alcoholists: Favorable and adverse effects
4.4.2.1 Hypericum perforatum L. (St. John's wort)
4.4.2.2 Pueraria lobate Willd. (Ohwi kudzu)
4.4.2.3 Salvia miltiorrhiza Bge. (Danshen)
4.4.2.4 Tabernanthe iboga H. Bn. (Ibogaine)
4.4.2.5 Panax ginseng C.A. Mey. (Ginseng)
4.4.2.6 Piper methysticum G. Forst. (Kava)
4.4.2.7 Morus nigra L. (mulberry) and Taraxacum coreanum Nakai (dandelion)
4.4.2.8 Hovenia dulcis Thunb. (Japanese raisin tree)
4.5 Conclusions
References
Chapter 5 Hepatoprotective activity of natural compounds and plant extracts in nonalcoholic fatty liver disease
5.1 Introduction
5.2 Nonalcoholic fatty liver disease pathogenesis and progression
5.3 Oxidative stress and lipotoxicity
5.4 Mediterranean diet and nonalcoholic fatty liver disease
5.5 Natural compound effects on nonalcoholic fatty liver disease
5.6 Conclusions
Acknowledgments
References
Chapter 6 Liver cancer
6.1 Introduction
6.2 Classification of hepatic cancers
6.2.1 Benign tumors
6.2.2 Malignant tumors
6.3 Causes of liver cancer
6.4 Diagnosis
6.4.1 Nuclear medical imaging
6.4.2 Single photon emission computed tomography (SPECT)
6.4.3 Liver puncture biopsy
6.4.4 Serological molecular markers for liver cancer.
6.4.5 Pathological diagnosis of liver cancer
6.4.6 Prevention
6.4.7 Treatment
6.4.7.1 Glycyrrhizin
6.4.7.2 Wogonin
6.4.7.3 Resveratrol
6.4.7.4 Curcumin
6.4.7.5 Silymarin
6.4.7.6 Rhein
6.4.7.7 Naringenin
6.4.7.8 Geniposide
6.4.7.9 Salvianolic acid B (or magnesium lithospermate B, SAB)
6.4.7.10 Oxymatrine (or kwoninone, OM)
6.4.7.11 Tetrandrine
6.4.7.12 Berberine
6.4.7.13 Others
6.5 Conclusion
Conflict of interest
References
Chapter 7 Chronic liver diseases
7.1 Introduction
7.2 Primary sclerosing cholangitis
7.3 Hepatic steatosis
7.4 Primary biliary cirrhosis
7.5 Liver fibrosis
7.6 The use of bioactive compounds and plant extracts in chronic liver diseases
7.7 Nutritional support in CLD
References
Chapter 8 Drug-induced hepatotoxicity
8.1 Background
8.2 Hepatotoxicity: An overview
8.3 Drug metabolic pathways of the liver and hepatotoxicity
8.4 Drug-induced hepatotoxicity: Mechanisms and risk factors
8.5 Epidemiological aspects
8.6 Hepatoprotective activity of natural compounds and plant extracts in drug-induced hepatotoxicity
8.7 Conclusion
References
Part 2 Influence of nutrients, plant extracts and natural compounds in liver diseases
Chapter 9 Influence of omega-3 fatty acids and monounsaturated fats in liver diseases
9.1 Introduction
9.2 Chemistry and classification of omega fatty acids
9.3 Conversion of ALA to EPA and DHA
9.4 Chemistry and classification of MUFA
9.5 Sources of omega-3 fatty acids and MUFAs
9.6 Metabolism of omega-3 fatty acids and monounsaturated fats
9.7 Role of omega-3 fatty acids and monounsaturated fats in various liver diseases
9.7.1 Nonalcoholic fatty liver disease (NAFLD)
9.7.2 Nonalcoholic steatohepatitis (NASH)
9.7.3 Fibrosis.
9.7.4 Hepatocellular carcinoma (HCC)
9.8 Conclusion
Conflict of interest
References
Chapter 10 Influence of vitamins (C, B 3, D, and E) in liver health
10.1 Introduction
10.2 Vitamin C
10.3 Vitamin B 3 (niacin)
10.4 Vitamin D
10.5 Vitamin E
10.6 Vitamin combinations and liver health
10.7 Conclusion
References
Chapter 11 Influence of other nutrients (e.g., l -arginine, taurine, and choline) on liver diseases
11.1 Introduction
11.2 Liver diseases
11.3 Arginine
11.3.1 Structural characteristics and metabolism
11.3.2 Functional links with the liver
11.3.3 Evidence of hepatoprotective functions
11.4 Taurine
11.4.1 Chemical structure and biological functions
11.4.2 Potential effects as a therapeutic agent
11.4.3 Clinical studies linked to liver diseases
11.5 Choline
11.5.1 Its metabolites and dietary sources
11.5.2 Aspects of its metabolism
11.5.3 Clinical evidence of the effect on liver health
11.6 Conclusions
References
Chapter 12 Antioxidants with hepatoprotective activity
12.1 Introduction
12.2 Natural hepatoprotective agents
12.2.1 Ursodeoxycholic acid
12.2.2 Choline
12.2.3 Betaine
12.2.4 S -Adenosyl- l -methionine
12.2.5 Melatonin
12.2.6 Glutathione
12.2.7 N -Acetylcysteine
12.2.8 Minerals in antioxidant enzymes
12.2.9 Vitamins E and C
12.2.10 Lycopene
12.2.11 Beta-carotene
12.2.12 Silymarin
12.2.13 Alpha-lipoic acid
12.2.14 Coenzyme Q10
12.2.15 Curcumin
12.2.16 Other natural antioxidants with hepatoprotective effects
12.3 Synthetic hepatoprotectors with antioxidant activity
12.3.1 Pentoxiyfylline
12.3.2 Angiotensin-converting enzyme inhibitors
12.4 Conclusion
References
Chapter 13 Plant extracts with putative hepatoprotective activity.
13.1 Introduction
13.2 Conclusion
References
Chapter 14 Plant extracts with putative hepatotoxicity activity
14.1 Introduction
14.2 General concepts of hepatotoxicity
14.2.1 Types of hepatotoxicity
14.2.1.1 Idiosyncratic form of liver injury
14.2.1.2 Intrinsic form of liver injury
14.2.2 Causes of hepatotoxicity
14.2.2.1 Hepatotoxicity induced by drugs
14.2.2.2 Hepatotoxicity induced by viruses
14.2.3 Mechanisms of hepatotoxicity
14.2.3.1 Bile acid accumulation
14.2.3.2 Activation of parenchymal cells
14.2.3.3 Activation of nonparenchymal cells
14.3 Hepatotoxicity induced by plant extracts and mushrooms
14.3.1 Atractylis gummifera L.
14.3.2 Morinda citrifolia L.
14.3.3 Camellia sinensis L.
14.3.4 Aloe vera L.
14.3.5 Teucrium chamaedrys L.
14.3.6 Chelidonium majus L.
14.3.7 Piper methysticum G. Forst
14.3.8 Larrea tridentata (Sess. & amp
Moc. ex DC.) Cov.
14.3.9 Mentha pulegium L.
14.3.10 Amanita phalloides (Vaill. ex Fr.: Fr.)
14.3.11 Viscum album L.
14.3.12 Xanthium strumarium L.
14.3.13 Scutellaria biacalensis Georgi
14.3.14 Callilepis laureola DC.
14.3.15 Valeriana officinalis L.
14.3.16 Hypericum perforatum L.
14.3.17 Cascara sagrada DC.
14.3.18 Cassia acutifolia Delile
14.3.19 Actaea racemosa L.
14.3.20 Echinaceae purpurea L.
14.4 Conclusion
Acknowledgments
References
Index.

Influence of nutrients, bioactive compounds and plant extracts in liver diseases /

Ejemplares similares